March 31, 2014 / 12:05 PM / 4 years ago

BRIEF-Bayer initiates two phase III trials with rivaroxaban in medically-ill patients and children at high risk of blood clots

FRANKFURT, March 31 (Reuters) - Bayer AG : * Says initiates two phase III trials with Rivaroxaban in medically-ill

patients and children at high risk of blood clots

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below